In a letter dated August 30,2019 from Marian Hollingsworth,Director of Publisher Relations for the Web of Science Group Clarivate Analytics,Philadelphia,PA,USA,we were informed that Genes&Diseases has been selecte...In a letter dated August 30,2019 from Marian Hollingsworth,Director of Publisher Relations for the Web of Science Group Clarivate Analytics,Philadelphia,PA,USA,we were informed that Genes&Diseases has been selected for Science Citation Index Expanded(SCIE)coverage in the Genetics&Heredity and Biochemistry&Molecular Biology categories of the Clarivate Analytics products and services.Beginning with Volume 4(1),2017,Genes&Diseases will be indexed and abstracted in Science Citation Index Expanded(SCIE,also known as SciSearch),Journal Citation Reports/Science Edition,Current Contents/Life Sciences,and Biological Abstracts.The first release of the journal’s Impact Factor(IF)is anticipated in June 2020.展开更多
Welcome to the inaugural issue of Genes&Diseases,a peerreviewed international journal that aims to facilitate a rapid dissemination and exchange of scientific advances about human diseases between basic science in...Welcome to the inaugural issue of Genes&Diseases,a peerreviewed international journal that aims to facilitate a rapid dissemination and exchange of scientific advances about human diseases between basic science investigators and physicians worldwide.Genes&Diseases focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases.Human medicine is undoubtedly a rapidly evolving field.The journal’s emphasis is placed on hypothesis-driven,mechanistic studies relevant to the pathogenesis and/or experimental therapeutics of human diseases.Thus,Genes&Diseases has a broad scope in basic and translational biomedical research related to molecular biology,molecular genetics,cell biology,and experimental medicine.The current publication formats include full length research article,review article,short communication,correspondence,perspectives,commentary,views on news,and research watch.展开更多
文摘In a letter dated August 30,2019 from Marian Hollingsworth,Director of Publisher Relations for the Web of Science Group Clarivate Analytics,Philadelphia,PA,USA,we were informed that Genes&Diseases has been selected for Science Citation Index Expanded(SCIE)coverage in the Genetics&Heredity and Biochemistry&Molecular Biology categories of the Clarivate Analytics products and services.Beginning with Volume 4(1),2017,Genes&Diseases will be indexed and abstracted in Science Citation Index Expanded(SCIE,also known as SciSearch),Journal Citation Reports/Science Edition,Current Contents/Life Sciences,and Biological Abstracts.The first release of the journal’s Impact Factor(IF)is anticipated in June 2020.
文摘Welcome to the inaugural issue of Genes&Diseases,a peerreviewed international journal that aims to facilitate a rapid dissemination and exchange of scientific advances about human diseases between basic science investigators and physicians worldwide.Genes&Diseases focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases.Human medicine is undoubtedly a rapidly evolving field.The journal’s emphasis is placed on hypothesis-driven,mechanistic studies relevant to the pathogenesis and/or experimental therapeutics of human diseases.Thus,Genes&Diseases has a broad scope in basic and translational biomedical research related to molecular biology,molecular genetics,cell biology,and experimental medicine.The current publication formats include full length research article,review article,short communication,correspondence,perspectives,commentary,views on news,and research watch.
